NMC Health Plc Total Voting Rights (2238S)

TIDMNMC

RNS Number : 2238S

NMC Health Plc

19 December 2016

19 December 2016

NMC Health plc

(the "Company" or "NMC")

Total Voting Rights

In accordance with the Financial Conduct Authority's Disclosure Guidance and Transparency Rules, NMC Health plc announces that the total number of ordinary shares of 10 pence each of the Company in issue at the date of this notice is 204,285,714, with each share carrying the right to one vote.

There are no shares held in Treasury.

The total number of voting rights in the Company is therefore 204,285,714.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

Enquiries:

NMC Health plc

Simon Watkins, Group Company Secretary

[phone]

Media:

FTI Consulting, London

Matthew Cole

[phone]

FTI Consulting, Gulf

Shane Dolan

[phone]

About NMC Health

The NMC group (the "Group") is the leading private sector healthcare operator in the United Arab Emirates, with a nation-wide network of hospitals and operations in the country since 1975. The Group currently operates or manages eight hospitals, two day-care patient centres, nine medical centres and fifteen pharmacies. In addition, the Group owns and operates Clinica Eugin in Barcelona, Spain - one of the leading fertility treatment centres globally. NMC also owns a 51 per cent. shareholding in Fakih IVF Group, the Middle East market leader for in-vitro fertilisation ("IVF") services. Moreover, NMC also owns and operates Americare Group, the leading home care provider in the UAE as well as ProVita, the pioneering provider of long-term medical care, also in the UAE. The enlarged company received almost 3.2 million patients in 2015. The Group is also a leading UAE supplier of products and consumables across several key market segments, with the major contribution coming from healthcare related products. The Group reported revenues of US$880.9 million for the year ended 31 December 2015.

In April 2012 NMC was listed on the Premium Segment of the London Stock Exchange. NMC is a constituent of the FTSE 250 Index.

This information is provided by RNS

The company news service from the London Stock Exchange

END

TVRFFLSUUFMSESE

(END) Dow Jones Newswires

December 19, 2016 04:06 ET (09:06 GMT)